<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkabbani, W</style></author><author><style face="normal" font="default" size="100%">Gamble, JM</style></author><author><style face="normal" font="default" size="100%">Eurich, DT</style></author><author><style face="normal" font="default" size="100%">Minhas-Sandu, J</style></author><author><style face="normal" font="default" size="100%">Shah, BR</style></author><author><style face="normal" font="default" size="100%">Alsabbagh, W</style></author><author><style face="normal" font="default" size="100%">Zongo, A</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Risk of hospitalization and death associated with Sodium Glucose Cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs.</style></title><secondary-title><style face="normal" font="default" size="100%">Diabetes and Metabolism</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2021</style></year></dates><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>